Brief: Sutro Biopharma Reports Second Quarter 2022 Financial Results, Business Highlights And Anticipated Milestones
08/08/2022 23:38
Sutro Biopharma Inc STRO.O :
* SUTRO BIOPHARMA REPORTS SECOND QUARTER 2022 FINANCIAL
RESULTS,
BUSINESS HIGHLIGHTS AND ANTICIPATED MILESTONES
* SUTRO BIOPHARMA - CASH, MARKETABLE SECURITIES AS OF JUNE
30,
2022, PAYMENT FROM ASTELLAS IN JULY 2022 PROVIDES PROJECTED CASH
RUNWAY INTO H1 OF 2024
* SUTRO BIOPHARMA INC - QTRLY LOSS PER SHARE $0.55
Source text for Eikon: ID:nGNX60hgjb
Further company coverage: STRO.O
Recent news on Sutro Biopharma
See all newsBrief: Sutro Biopharma Announces First Patient Dosed In Phase 1 Trial Of STRO-006
U.S. STOCKS ON THE MOVE-Sutro Biopharma, Humacyte, CoreWeave
U.S. STOCKS ON THE MOVE-Sutro Biopharma, Humacyte
Sutro Biopharma Inc reports results for the quarter ended June 30 - Earnings Summary
Sutro Biopharma tumbles after missing estimates